CureZone   Log On   Join
Adcetris 50 mg: As An Antibody-Drug Conjugate
 
dollyroy Views: 30
Published: 44 days ago
 

Adcetris 50 mg: As An Antibody-Drug Conjugate


Introduced as an antibody-drug conjugate, the Adcetris 50 mg is recommended for treating patients with relapsed or refractory Hodgkin lymphoma and patients with anaplastic large cell lymphoma. The adcetris 50 mg injection should be administered under the close supervision of a doctor experienced in the use of anti-cancer agents. The standard dose of adcetris should be given by a healthcare professional as an intravenous (IV) infusion.


https://issuu.com/home/published/brentuximab_injection.docx
 

 
Printer-friendly version of this page Email this message to a friend
Alert Moderators
Report Spam or bad message  Alert Moderators on This GOOD Message

This Forum message belongs to a larger discussion thread. See the complete thread below. You can reply to this message!


 

Donate to CureZone


CureZone Newsletter is distributed in partnership with https://www.netatlantic.com


Contact Us - Advertise - Stats

Copyright 1999 - 2022  www.curezone.com

2.359 sec, (1)